SPRU Learn

Spirulina and Blood Sugar: What Research Suggests

Human studies of spirulina supplements report different blood-glucose outcomes. They did not test SPRU and do not establish a diabetes benefit for our fresh-frozen product.

One review found no significant HbA1c or post-meal effect
A later add-on trial reported changes while participants continued metformin
Neither study tested SPRU

This guide looks at human research on spirulina supplements and blood-glucose measures. The studies did not test SPRU fresh-frozen spirulina, so they do not establish that SPRU prevents, treats or manages diabetes.

Systematic review and meta-analysis

A 2021 review pooled eight studies (nine study arms) of spirulina supplementation in people with type 2 diabetes. It reported a reduction in fasting blood glucose, but no statistically significant effect on HbA1c or post-meal blood glucose. The included studies differed, which limits how confidently the pooled result can be applied. Read the review on PubMed.

One add-on trial

A 2023 randomised, double-blind trial assigned 60 adults with inadequately controlled type 2 diabetes to spirulina or placebo for three months while participants continued metformin. The researchers reported lower HbA1c and fasting blood glucose in the spirulina group. This was a supplement trial alongside usual treatment—not a test of SPRU or a reason to change prescribed care. Read the trial on PubMed.

What the studies do—and do not—show

These studies concern specific supplements, doses and study groups. They do not establish a diabetes benefit for SPRU fresh-frozen spirulina. Do not change medication or treatment based on this research; discuss care decisions with your healthcare professional.